Los Angeles Times. June 26, 2011. Diana Zuckerman warns about the possibility of unknown autoimmune diseases linked to breast implants and criticizes implant manufacturers for failing to meet safety study benchmarks required by the FDA.
Associated Press. January 26-27, 2011. Federal health officials (FDA) said Wednesday they are investigating a possible link between breast implants and a very rare form of cancer, raising new questions about the safety of devices which have been scrutinized for decades.
The Washington Post, January 5, 2010; A04
December 16, 2010. FDA made the right decision in starting the process to remove the breast cancer indication for Avastin.
KEZI, Wednesday July 21, 2010
KTNV, Wednesday July 21, 2010 10:03 pm EDT